Rezza G, Cereda D, Rizzo C, et al. Nirsevimab: a change of paradigm in the prophylaxis of Respiratory Syncytial Virus disease among infants. Ann Ig. 2025;37(5):684-688. doi:10.7416/ai.2025.2712